Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 41

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 41
---
 that give Alcon an opportunity to negotiate to modify the
terms of the Merger Agreement in a manner such that any Acquisition Proposal would not constitute a Superior Offer. In some circumstances, upon termination of the Merger Agreement, STAAR will be required to pay a termination fee to Alcon of
$43,425,000, although this fee will be reduced to $14,475,000 upon termination of the Merger Agreement under certain circumstances in the case of an acquiror who makes an Acquisition Proposal which, before the expiration of the 45-day window shop period, the Board determines constitutes or could reasonably be expected to lead to a Superior Offer. The window shop period ends at 11:59 p.m., Eastern Time, on September 19, 2025. For more
information, see “The Merger Agreement—Non Solicitation; Window Shop Period” and “—Termination Fees.”

These provisions could discourage a potential third-party acquiror that might have an interest in acquiring all or a significant portion of
STAAR from considering or proposing an acquisition, even if the acquiror was prepared to pay a greater amount of value than the Merger Consideration that STAAR stockholders would be afforded by the Merger, or could result in a potential third-party
acquiror proposing to pay a lower amount of value to STAAR’s stockholders than they might otherwise have proposed due to the added expense of the termination fee that may become payable to Alcon in certain circumstances.

-25-

Lawsuits may be filed against STAAR or its directors or officers challenging the transactions contemplated by the Merger Agreement or the Merger, which could prevent or delay the completion of the Merger or result in the payment of damages.

Litigation relating to the Merger has been filed, and additional litigation relating to the Merger may be filed against STAAR or its directors
or officers. Among other remedies, claimants could seek damages and/or to enjoin the Merger and the other transactions contemplated by the Merger Agreement. An adverse ruling in any such lawsuit may delay or prevent the proposed Merger from being
completed. Any such actions may create uncertainty relating to the Merger and may be costly and distracting to STAAR’s management.

Additionally, if the Merger is not consummated for any reason, litigation could be filed in connection with the failure to consummate the
Merger.

If the Merger is consummated, STAAR stockholders will not be able to participate in any further